Literature DB >> 31745705

Prediction of P-glycoprotein inhibitors with machine learning classification models and 3D-RISM-KH theory based solvation energy descriptors.

Vijaya Kumar Hinge1, Dipankar Roy1, Andriy Kovalenko2,3.   

Abstract

Development of novel in silico methods for questing novel PgP inhibitors is crucial for the reversal of multi-drug resistance in cancer therapy. Here, we report machine learning based binary classification schemes to identify the PgP inhibitors from non-inhibitors using molecular solvation theory with excellent accuracy and precision. The excess chemical potential and partial molar volume in various solvents are calculated for PgP± (PgP inhibitors and non-inhibitors) compounds with the statistical-mechanical based three-dimensional reference interaction site model with the Kovalenko-Hirata closure approximation (3D-RISM-KH molecular theory of solvation). The statistical importance analysis of descriptors identified the 3D-RISM-KH based descriptors as top molecular descriptors for classification. Among the constructed classification models, the support vector machine predicted the test set of Pgp± compounds with highest accuracy and precision of ~ 97% for test set. The validation of models confirms the robustness of state-of-the-art molecular solvation theory based descriptors in identification of the Pgp± compounds.

Entities:  

Keywords:  3D-RISM-KH; Excess chemical potential; Multidrug resistance (MDR); P-glycoprotein (PgP); Partial molar volume (PMV); PgP inhibitors; Solvation free energy

Year:  2019        PMID: 31745705     DOI: 10.1007/s10822-019-00253-5

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  47 in total

1.  Chemosensitizers to overcome and prevent multidrug resistance?

Authors:  U A Germann; M W Harding
Journal:  J Natl Cancer Inst       Date:  1995-11-01       Impact factor: 13.506

Review 2.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

3.  ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques.

Authors:  Lei Chen; Youyong Li; Qing Zhao; Hui Peng; Tingjun Hou
Journal:  Mol Pharm       Date:  2011-03-25       Impact factor: 4.939

4.  A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.

Authors:  Ronan J Kelly; Deborah Draper; Clara C Chen; Robert W Robey; William D Figg; Richard L Piekarz; Xiaohong Chen; Erin R Gardner; Frank M Balis; Aradhana M Venkatesan; Seth M Steinberg; Tito Fojo; Susan E Bates
Journal:  Clin Cancer Res       Date:  2010-11-16       Impact factor: 12.531

5.  Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates.

Authors:  Sean Ekins; Richard B Kim; Brenda F Leake; Anne H Dantzig; Erin G Schuetz; Lu-Bin Lan; Kazuto Yasuda; Robert L Shepard; Mark A Winter; John D Schuetz; James H Wikel; Steven A Wrighton
Journal:  Mol Pharmacol       Date:  2002-05       Impact factor: 4.436

Review 6.  Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.

Authors:  R Krishna; L D Mayer
Journal:  Eur J Pharm Sci       Date:  2000-10       Impact factor: 4.384

7.  Combined QSAR and molecule docking studies on predicting P-glycoprotein inhibitors.

Authors:  Wen Tan; Hu Mei; Li Chao; Tengfei Liu; Xianchao Pan; Mao Shu; Li Yang
Journal:  J Comput Aided Mol Des       Date:  2013-12-10       Impact factor: 3.686

8.  Synthesis, biological evaluation and 3D-QSAR studies of new chalcone derivatives as inhibitors of human P-glycoprotein.

Authors:  Zahida Parveen; Gerda Brunhofer; Ishrat Jabeen; Thomas Erker; Peter Chiba; Gerhard F Ecker
Journal:  Bioorg Med Chem       Date:  2014-02-15       Impact factor: 3.641

Review 9.  P-glycoprotein Inhibition for Optimal Drug Delivery.

Authors:  Md Lutful Amin
Journal:  Drug Target Insights       Date:  2013-08-19

10.  Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.

Authors:  Safiulla Basha Syed; Hemant Arya; I-Hsuan Fu; Teng-Kuang Yeh; Latha Periyasamy; Hsing-Pang Hsieh; Mohane Selvaraj Coumar
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

View more
  3 in total

Review 1.  Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches.

Authors:  Hyunho Kim; Eunyoung Kim; Ingoo Lee; Bongsung Bae; Minsu Park; Hojung Nam
Journal:  Biotechnol Bioprocess Eng       Date:  2021-01-07       Impact factor: 3.386

Review 2.  Biomolecular Simulations with the Three-Dimensional Reference Interaction Site Model with the Kovalenko-Hirata Closure Molecular Solvation Theory.

Authors:  Dipankar Roy; Andriy Kovalenko
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

Review 3.  Machine learning models for classification tasks related to drug safety.

Authors:  Anita Rácz; Dávid Bajusz; Ramón Alain Miranda-Quintana; Károly Héberger
Journal:  Mol Divers       Date:  2021-06-10       Impact factor: 3.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.